Actively Recruiting
Night Owl Metabolism
Led by Johns Hopkins University · Updated on 2026-05-11
70
Participants Needed
1
Research Sites
257 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
L
Lawson Wilkins Pediatric Endocrine Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
The proposed study uses a novel and rigorous randomized cross-over study design in youth (18-23y) with late and non-late chronotype (n=35 per group) to assess the glycemic effect of "aligning" an oral glucose tolerance test (OGTT) or first-meal of day to a subject's chronotype. Both groups will undergo 2 OGTTs (aligned and mis-aligned with chronotype) to compare glucose tolerance and insulin sensitivity within-subject (primary outcome) and between groups (Aim 1). Then, youth will also undergo two standardized meals (aligned and mis-aligned with chronotype) while wearing continuous glucose monitoring to compare post-prandial glucose excursions within-subject and between groups (Aim 2). A pilot Exploratory Aim 3 (n=12 per group) will investigate delayed melatonin patterns under dim-light as a potential pathophysiologic mechanism behind abnormal glucose tolerance in youth with late chronotype on morning OGTTs.
CONDITIONS
Official Title
Night Owl Metabolism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Overweight with BMI at or above the 85th percentile but below the 95th percentile for age and sex (or equivalent for 20-year-olds if age 21-23)
- Post-pubertal
- Normal sleep duration averaging more than 7 hours per night
- Social jetlag (difference between weekend and weekday sleep) less than 2 hours
You will not qualify if you...
- Known diabetes, sleep disorders, major organ system illness, pregnancy, or genetic syndromes
- Use of medications affecting insulin sensitivity, glucose tolerance, or circadian rhythm
- High risk for obstructive sleep apnea based on screening
- Night shift work
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Johns Hopkins School of Medicine
Baltimore, Maryland, United States, 21287
Actively Recruiting
Research Team
T
Talia Hitt, MD/MPH/MSHP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here